Ethyl p-methoxycinnamate from Kaempferia galanga inhibits angiogenesis through tyrosine kinase

Main Article Content

Juni Ekowati
Suko Hardjono
Iwan Sahrial Hamid


Many tumors express on their receptor tyrosine kinases vascular endothelial
growth factor activity associated with angiogenesis. Inhibition of
angiogenesis through reduction of tyrosine kinase activity is a promising
strategy for cancer therapy. The present study aimed to determine the
mechanism and potency of ethyl p-methoxycinnamate (EPMC) isolated
from Kaempferia galanga as angiogenesis inhibitor.
A laboratory experimental study was conducted using chorio-allantoic
membranes (CAMs) of nine-day old chicken eggs induced by 60ng basic
fibroblast growth factor (bFGF). Ethyl p-methoxycinnamate (EPMC) potency
was determined at dosages of 30, 60, 90 and 120 μg and compared with
celecoxib 60 μg as reference drug and one negative bFGF-induced control
group. Neovascularization and endothelial cell count in CAM blood vessels
were evaluated. To predict the antiangiogenic mechanism of EPMC, a
docking study was performed with the Molegro Virtual Docker program on
tyrosine kinase as receptor (PDB 1XKK).
Angiogenesis stimulation by bFGF was prevented significantly (p<0.05)
by EPMC at dosages of 30, 60, 90 and 120 μg and this activity was dose
dependent. Molecular docking showed interaction between EPMC functional
groups and tyrosine kinase amino acids at Met766, Met793, Thr854, Thr790,
Gln791 and Ala743. There was an association between EPMC
antiangiogenic activity and docking study results.
Ethyl p-methoxycinnamate is a potential new angiogenesis inhibitor through
interaction with tyrosine kinase. EPMC could be a promising therapeutic
agent for treatment of angiogenesis-related diseases.

Article Details

How to Cite
Ekowati, J., Hardjono, S., & Hamid, I. S. (2015). Ethyl p-methoxycinnamate from Kaempferia galanga inhibits angiogenesis through tyrosine kinase. Universa Medicina, 34(1), 43–51.
Review Article
Author Biographies

Juni Ekowati, Airlangga University Surabaya

Department of Pharmaceutical Chemistry, Faculty of Pharmacy

Suko Hardjono, Airlangga University, surabaya

Department of Pharmaceutical
Chemistry, Faculty of Pharmacy

Iwan Sahrial Hamid, Airlangga University, Surabaya

Department of Molecular Pharmacology,
Faculty of Veterinary Medicine,


Gotink KJ, Verheul HMW. Anti-angiogenic tyrosinee kinase inhibitors: what is their mechanism of action? Angiogenesis 2010;13:1-14.

Filho AL, Lopes JM, Schmitt FC. Angiogenesis and breast cancer. J Oncol 2010. doi: 10.1155/2010/576384.

Kyzas PA, Stefanou D, Agnantis NJ. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 2005;18:153-60.

Athikomkulchai S, Vaymhasuwan P, Tunvichien S, et al. The development of sunscreen product from Kaempferia galanga. J Health Res 2007;21:253-6.

Kusumawati I, Yusuf H. Phospholipid complex as a carrier of Kaempferia galanga rhizoma extract to improve its analgesic activity. IJPPS 2011;3 Suppl 1:S44-6.

Umar MI, Asnawi MZ, Sadikun A, et al. Ethyl p-methoxycinnamate isolated from Kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-?and angiogenesis by blocking endothelial functions.

Clinics 2014;69:134-44.

Aroonrerk N, Kamkaen N. Anti-inflammatory activity of Quercus Infectoria, Glycyrrhiza Uralensis, Kaempferia galanga and Coptis Chinensis: the main components of Thai herbal

remedies for aphthous ulcer. J Health Res 2009; 23:17-22.

Ekowati J, Bimo AT, Sukardiman, et al. Structure modification of ethyl p-methoxycinnamate and their bioassay as chemopreventive agent against mice’s fibrosarcoma. IJPPS 2012;4 Suppl 3:S528-32.

Greehough A, Smart HJM, Moore AE, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinog 2009;30:377-86.

Yao L, Liu F, Hong L, et al. The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. J Exp Clin Cancer Res 2011;30:13.doi:10.1186/1756-9966-30-13.

Roskoski R. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 2007;356:323-8.

He ZH, Yue GG, Lau CB, et al. Antiangiogenic effects and mechanisms of trans-ethyl pmethoxycinnamate from Kaempferia galanga L. J Agric Food Chem 2012;60:11309-17.

Ribatti D. The chick embryo chorioallantoic membrane as in vivo assay to study antiangiogenesis. Pharm 2010;3:482-513.

Lokman NA, Elder ASF, Ricciardelli C, Oehler MK. Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer

invasion and metastasis. Intern J Molec Sci 2012;13:9959-70. doi: 10.3390/ijms13089959.

Kusumaningrum S, Budianto E, Kosela S, et al. The molecular docking of 1,4-naphthoquinone derivatives as inhibitors of polo-like kinase 1 using Molegro Virtual Docker. J App Sci 2014;4: 47-53.

Diyah NW, Ekowati J, Siswandono. Synthesis and anti tumor activity evaluation of N, N’-dibenzoyl-N,N’-diethylurea against human breast cancer cell line (MCF-7). IJPPS 2014;6:315-8.

Salamah N, Sugiyanto, Hartati MS, et al. Isolasi dan identifikasi eurycomanone akar pasak bumi (Eurycoma longifolia, Jack) serta uji anti angiogenik. Majalah Farmasi Indonesia 2009;20:118-26.

Kumar BNP, Rajput S, Dey KK, et al. Celecoxib alleviates tamoxifen-instigated angiogenic effect 51 by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer 2013;13:273. doi: 10. 1186/1471-2407-13-273.

Klenke FM, Gebhard M, Ewerbeck V, et al. The selective COX-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC Cancer 2006;6:9. doi:10.1186/1471-2407- 6-9.

Altun A, Temiz TK, Balci E, et al. Effects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combination. Chin J Cancer Res 2013;25:572-

Wang L, Chen W, Xie X, et al. Celecoxib inhibits tumor growth and angiogenesis in an othotopic implantation tumor model of human cancer. Exp Oncol 2008;30:42–51.

Fox SB, Generally DG, Harris AL. Review breast tumor angiogenesis. Breast Cancer Res 2007;9:1-11.

Zittermann SI, Issekutz AC. Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule

expression. Am J Patol 2006;168:835-46.

Sahin E. Cyclooxygenase-1 in cancer and angiogenesis. Angiology 2009;60:242-53.

Ekowati J, Tejo BA, Susilo I, et al. Microwave assisted synthesis of ethyl p-methoxycinnamate derivative and its activity to blockade COX-2 expression on breast cancer cell line. Proceeding of the 3rd ICPAPS; 2013 June 18-19. Yogyakarta.

p.32-8. Univ Med Vol. 34 No.1